Related Experiment Videos
[Hyperhomocysteinemia and vascular disease]
1Istituto di Fisiologia Clinica, Consiglio Nazionale delle Ricerche e Scuola Superiore di Studi Universitari e di Perfezionamento S. Anna, Pisa.
Insights
High homocysteine levels (hyperhomocysteinemia) are linked to atherosclerosis. Understanding how elevated homocysteine damages blood vessels, particularly endothelial cells, is crucial for developing new treatments.
Area of Science:
- Cardiovascular Research
- Metabolic Disorders
- Vascular Biology
Context:
- Hyperhomocysteinemia, elevated plasma homocysteine, is increasingly recognized in atherosclerosis.
- Both hereditary and acquired forms of hyperhomocysteinemia may contribute significantly to adult atherosclerosis.
- Current knowledge of homocysteine's vascular damage mechanisms remains incomplete.
Purpose:
- To investigate the role of hyperhomocysteinemia in atherosclerosis.
- To elucidate the mechanisms by which elevated homocysteine causes vascular damage.
- To identify endothelial cells as a primary target of homocysteine toxicity.
Summary:
- Hyperhomocysteinemia is a metabolic disorder associated with increased atherosclerosis risk.
- Endothelial cells are identified as a key target of homocysteine-induced vascular damage, potentially via oxidative stress.
- Further understanding of these mechanisms is needed to improve prevention and treatment strategies.
Impact:
- Improved understanding of homocysteine's role in vascular disease.
- Potential for developing targeted therapies for atherosclerosis.
- Enhanced strategies for preventing and treating homocysteine-related vascular complications.
Abstract:
Hyperhomocysteinemia, the pathological increase of plasma homocysteine concentrations, is gaining increased attention in atheroscierosis research. Reasons for the wide present interest for this disorder of metabolism are that it may account, in the hereditary heterozygous and the acquired forms, for a still undetermined but possibly very large number of clinical manifestations of atheroscierosis in the adult population; and that the current understanding of the mechanisms by which high plasma concentrations of homocysteine induce vascular damage is presently to a large extent incomplete. As indicated by several lines of evidence, the endothelial cell appears to be the main target for the sustained toxic aggression by hyperomocysteinemia, possibly through the generation of an enhanced oxidative stress. A better understanding of the causes and mechanisms of homocysteine-induced vascular damage will likely lead to the development of better targeted preventive and therapeutical approaches in vascular disease.